Tapewire

Nasdaq · USD

OM

Outset Medical, Inc.

Export transactions ↓
Tapewire entity
7026
SEC CIK
0001484612
Parsed reports
379

Last 12 months

Inside the activity.

2 purchase rows · 23 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202501
Jan 202609
Feb 202603
Mar 202600
Apr 202600
May 202603
Jun 202601
Jul 202600
Aug 202603
Sep 202600
Oct 202620

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 27, 2023 Filed Jan 30, 2023 21:44 UTC
Racine Jean-OlivierChief Technology Officer
SaleCommon Stock 2,066 $27.92 $57,682.72
Disclosure

SEC source: 0001484612-23-000013 · edgardoc.xml · nonDerivative · entry 1

Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,288

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 7,162 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
January 27, 2023 Filed Jan 30, 2023 21:43 UTC
Porter Stacey L.Chief People Officer
SaleCommon Stock 2,295 $27.92 $64,076.40
Disclosure

SEC source: 0001484612-23-000012 · edgardoc.xml · nonDerivative · entry 1

Porter Stacey L. · CIK 0001889204 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,535

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 5,534 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
January 27, 2023 Filed Jan 30, 2023 21:40 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 4,938 $27.92 $137,868.96
Disclosure

SEC source: 0001484612-23-000010 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,909

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 9,116 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
January 06, 2023 Filed Jan 9, 2023 21:55 UTC
Brottem John L.General Counsel
GrantCommon Stock 2,184 $0.00 $0.00
Disclosure

SEC source: 0001484612-23-000007 · edgardoc.xml · nonDerivative · entry 2

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,062

F2 · shares: Represents portion of stock units granted to the reporting person on January 6, 2023 that will vest on December 31, 2025, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock.

Read SEC document
January 06, 2023 Filed Jan 9, 2023 21:55 UTC
Brottem John L.General Counsel
GrantCommon Stock 38,834 $0.00 $0.00
Disclosure

SEC source: 0001484612-23-000007 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,878

F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 6, 2023. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 6, 2024, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.

Read SEC document
January 06, 2023 Filed Jan 9, 2023 16:53 UTC
Vazquez MartinChief Operating Officer
GrantCommon Stock 3,185 $0.00 $0.00
Disclosure

SEC source: 0001484612-23-000005 · edgardoc.xml · nonDerivative · entry 2

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,109

F2 · shares: Represents portion of stock units granted to the reporting person on January 6, 2023 that will vest on December 31, 2025, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock.

Read SEC document
January 06, 2023 Filed Jan 9, 2023 16:53 UTC
Vazquez MartinChief Operating Officer
GrantCommon Stock 56,634 $0.00 $0.00
Disclosure

SEC source: 0001484612-23-000005 · edgardoc.xml · nonDerivative · entry 1

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,924

F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 6, 2023. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 6, 2024, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.

Read SEC document
January 06, 2023 Filed Jan 9, 2023 21:57 UTC
Porter Stacey L.Chief People Officer
GrantCommon Stock 1,939 $0.00 $0.00
Disclosure

SEC source: 0001484612-23-000009 · edgardoc.xml · nonDerivative · entry 2

Porter Stacey L. · CIK 0001889204 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,830

F2 · shares: Represents portion of stock units granted to the reporting person on January 6, 2023 that will vest on December 31, 2025, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock.

Read SEC document
January 06, 2023 Filed Jan 9, 2023 21:57 UTC
Porter Stacey L.Chief People Officer
GrantCommon Stock 34,466 $0.00 $0.00
Disclosure

SEC source: 0001484612-23-000009 · edgardoc.xml · nonDerivative · entry 1

Porter Stacey L. · CIK 0001889204 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,891

F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 6, 2023. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 6, 2024, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.

Read SEC document
January 06, 2023 Filed Jan 9, 2023 21:56 UTC
Racine Jean-OlivierChief Technology Officer
GrantCommon Stock 2,184 $0.00 $0.00
Disclosure

SEC source: 0001484612-23-000008 · edgardoc.xml · nonDerivative · entry 2

Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,354

F2 · shares: Represents portion of stock units granted to the reporting person on January 6, 2023 that will vest on December 31, 2025, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock.

Read SEC document
January 06, 2023 Filed Jan 9, 2023 21:56 UTC
Racine Jean-OlivierChief Technology Officer
GrantCommon Stock 38,834 $0.00 $0.00
Disclosure

SEC source: 0001484612-23-000008 · edgardoc.xml · nonDerivative · entry 1

Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,170

F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 6, 2023. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 6, 2024, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.

Read SEC document
January 06, 2023 Filed Jan 9, 2023 21:52 UTC
Williamson Steven S.Chief Commercial Officer
GrantCommon Stock 3,641 $0.00 $0.00
Disclosure

SEC source: 0001484612-23-000004 · edgardoc.xml · nonDerivative · entry 2

Williamson Steven S. · CIK 0001478582 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,188

F2 · shares: Represents portion of stock units granted to the reporting person on January 6, 2023 that will vest on December 31, 2025, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock.

Read SEC document
January 06, 2023 Filed Jan 9, 2023 21:52 UTC
Williamson Steven S.Chief Commercial Officer
GrantCommon Stock 64,724 $0.00 $0.00
Disclosure

SEC source: 0001484612-23-000004 · edgardoc.xml · nonDerivative · entry 1

Williamson Steven S. · CIK 0001478582 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,547

F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 6, 2023. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 6, 2024, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.

Read SEC document
January 06, 2023 Filed Jan 9, 2023 21:51 UTC
Trigg LeslieDirector · Chair and CEO
GrantCommon Stock 23,893 $0.00 $0.00
Disclosure

SEC source: 0001484612-23-000003 · edgardoc.xml · nonDerivative · entry 2

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 420,325

F2 · shares: Represents portion of stock units granted to the reporting person on January 6, 2023 that will vest on December 31, 2025, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock.

Read SEC document
January 06, 2023 Filed Jan 9, 2023 21:51 UTC
Trigg LeslieDirector · Chair and CEO
GrantCommon Stock 106,189 $0.00 $0.00
Disclosure

SEC source: 0001484612-23-000003 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 396,432

F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 6, 2023. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 6, 2024, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.

Read SEC document
January 06, 2023 Filed Jan 9, 2023 21:54 UTC
Ahmed NabeelChief Financial Officer
GrantCommon Stock 3,185 $0.00 $0.00
Disclosure

SEC source: 0001484612-23-000006 · edgardoc.xml · nonDerivative · entry 2

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,847

F2 · shares: Represents portion of stock units granted to the reporting person on January 6, 2023 that will vest on December 31, 2025, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock.

Read SEC document
January 06, 2023 Filed Jan 9, 2023 21:54 UTC
Ahmed NabeelChief Financial Officer
GrantCommon Stock 56,634 $0.00 $0.00
Disclosure

SEC source: 0001484612-23-000006 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,662

F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 6, 2023. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 6, 2024, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 17:15 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionPerformance Options (right to buy) · Derivative 5,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-23-000002 · edgardoc.xml · derivative · entry 3

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,007

Underlying: Common Stock · 5,000 shares

Expires 2027-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 17:15 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 5,000 $26.14 $130,716.00
Disclosure

SEC source: 0001484612-23-000002 · edgardoc.xml · nonDerivative · entry 2

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,290

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $25.00 - $25.99 - 1,991 shares; $26.00 - $26.99 - 3,009 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 17:15 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionCommon Stock 5,000 $3.88 $19,400.00
Disclosure

SEC source: 0001484612-23-000002 · edgardoc.xml · nonDerivative · entry 1

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,290

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 22:13 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionPerformance Options (right to buy) · Derivative 30,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-23-000001 · edgardoc.xml · derivative · entry 4

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,508

Underlying: Common Stock · 30,000 shares

Expires 2027-09-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 22:13 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 30,000 $25.26 $757,728.00
Disclosure

SEC source: 0001484612-23-000001 · edgardoc.xml · nonDerivative · entry 2

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,243

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $24.00 - $24.99 - 12,402 shares; $25.00 - $25.99 - 14,060 shares; $26.00 - $26.99 - 3,538 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 22:13 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionCommon Stock 30,000 $3.88 $116,400.00
Disclosure

SEC source: 0001484612-23-000001 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 320,243

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2022 Filed Dec 2, 2022 18:14 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionPerformance Options (right to buy) · Derivative 5,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-22-000083 · edgardoc.xml · derivative · entry 3

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,007

Underlying: Common Stock · 5,000 shares

Expires 2027-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
December 01, 2022 Filed Dec 2, 2022 18:14 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 5,000 $20.85 $104,250.00
Disclosure

SEC source: 0001484612-22-000083 · edgardoc.xml · nonDerivative · entry 2

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,290

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.

Read SEC document
December 01, 2022 Filed Dec 2, 2022 18:14 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionCommon Stock 5,000 $3.88 $19,400.00
Disclosure

SEC source: 0001484612-22-000083 · edgardoc.xml · nonDerivative · entry 1

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,290

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2022 Filed Dec 2, 2022 23:13 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionPerformance Options (right to buy) · Derivative 21,283 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-22-000082 · edgardoc.xml · derivative · entry 7

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,508

Underlying: Common Stock · 21,283 shares

Expires 2027-09-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
December 01, 2022 Filed Dec 2, 2022 23:13 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionPerformance Options (right to buy) · Derivative 8,717 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-22-000082 · edgardoc.xml · derivative · entry 6

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,791

Underlying: Common Stock · 8,717 shares

Expires 2027-09-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
December 01, 2022 Filed Dec 2, 2022 23:13 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 21,283 $20.85 $443,750.55
Disclosure

SEC source: 0001484612-22-000082 · edgardoc.xml · nonDerivative · entry 4

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,243

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022.

Read SEC document
December 01, 2022 Filed Dec 2, 2022 23:13 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionCommon Stock 21,283 $3.88 $82,578.04
Disclosure

SEC source: 0001484612-22-000082 · edgardoc.xml · nonDerivative · entry 3

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 311,526

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 01, 2022 Filed Dec 2, 2022 23:13 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 8,717 $20.85 $181,749.45
Disclosure

SEC source: 0001484612-22-000082 · edgardoc.xml · nonDerivative · entry 2

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,243

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022.

Read SEC document
December 01, 2022 Filed Dec 2, 2022 23:13 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionCommon Stock 8,717 $3.88 $33,821.96
Disclosure

SEC source: 0001484612-22-000082 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,960

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 01:00 UTC
Brottem John L.General Counsel
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 12,761 $0.00 Strike: $9.48 $0.00
Disclosure

SEC source: 0001484612-22-000081 · edgardoc.xml · derivative · entry 3

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,462

Underlying: Common Stock · 12,761 shares

Expires 2030-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 01:00 UTC
Brottem John L.General Counsel
SaleCommon Stock 12,761 $20.34 $259,497.49
Disclosure

SEC source: 0001484612-22-000081 · edgardoc.xml · nonDerivative · entry 2

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,044

F1 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $20.29 to $20.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.

Read SEC document
November 30, 2022 Filed Dec 2, 2022 01:00 UTC
Brottem John L.General Counsel
Exercise / conversionCommon Stock 12,761 $9.48 $120,974.28
Disclosure

SEC source: 0001484612-22-000081 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,805

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 22, 2022 Filed Nov 23, 2022 00:15 UTC PurchaseCommon Stock 7,500 $17.84 $133,800.00
Disclosure

SEC source: 0001484612-22-000080 · edgardoc.xml · nonDerivative · entry 1

Hinrichs James F. · CIK 0001506974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,668

F1 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were purchased in multiple transactions at prices ranging from: $17.76 - $17.90 The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · balance_after: These shares of common stock of the Issuer ("Shares"), purchased on November 22, 2022, are held directly by James Hinrichs IRA Rollover, Charles Schwab & Co Inc Custodian.

Read SEC document
November 18, 2022 Filed Nov 22, 2022 01:30 UTC
Brottem John L.General Counsel
SaleCommon Stock 1,918 $19.00 $36,442.00
Disclosure

SEC source: 0001484612-22-000079 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,044

Read SEC document
November 16, 2022 Filed Nov 17, 2022 21:29 UTC
Brottem John L.General Counsel
SaleCommon Stock 352 $19.28 $6,786.56
Disclosure

SEC source: 0001484612-22-000078 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,962

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 698 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
November 16, 2022 Filed Nov 17, 2022 16:18 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 260 $19.29 $5,015.40
Disclosure

SEC source: 0001484612-22-000075 · edgardoc.xml · nonDerivative · entry 1

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,290

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 516 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
November 16, 2022 Filed Nov 17, 2022 21:26 UTC
Racine Jean-OlivierChief Technology Officer
SaleCommon Stock 292 $19.29 $5,632.68
Disclosure

SEC source: 0001484612-22-000077 · edgardoc.xml · nonDerivative · entry 1

Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,336

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,180 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
November 16, 2022 Filed Nov 17, 2022 21:25 UTC
Williamson Steven S.Chief Commercial Officer
SaleCommon Stock 3,422 $19.29 $66,010.38
Disclosure

SEC source: 0001484612-22-000076 · edgardoc.xml · nonDerivative · entry 1

Williamson Steven S. · CIK 0001478582 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,823

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 10,000 shares of Common Stock underlying RSUs granted to the reporting person on November 15, 2020. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 500 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2021 to February 28, 2022. This transaction is exempt from Rule 16b-3(c).

Read SEC document
November 16, 2022 Filed Nov 17, 2022 21:15 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 916 $19.29 $17,669.64
Disclosure

SEC source: 0001484612-22-000074 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 290,243

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,821 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
November 16, 2022 Filed Nov 17, 2022 21:15 UTC
Porter Stacey L.Chief People Officer
SaleCommon Stock 34 $19.29 $655.86
Disclosure

SEC source: 0001484612-22-000073 · edgardoc.xml · nonDerivative · entry 2

Porter Stacey L. · CIK 0001889204 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,425

F2 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 93 shares of Common Stock underlying RSUs granted to the reporting person on October 22, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
November 16, 2022 Filed Nov 17, 2022 21:15 UTC
Porter Stacey L.Chief People Officer
SaleCommon Stock 105 $19.29 $2,025.45
Disclosure

SEC source: 0001484612-22-000073 · edgardoc.xml · nonDerivative · entry 1

Porter Stacey L. · CIK 0001889204 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,459

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 298 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
November 16, 2022 Filed Nov 17, 2022 21:04 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 264 $19.29 $5,092.56
Disclosure

SEC source: 0001484612-22-000072 · edgardoc.xml · nonDerivative · entry 2

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,028

F2 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 524 shares of Common Stock underlying RSUs granted to the reporting person on August 5, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
November 16, 2022 Filed Nov 17, 2022 21:04 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 121 $19.29 $2,334.09
Disclosure

SEC source: 0001484612-22-000072 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,292

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 239 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
November 11, 2022 Filed Nov 14, 2022 19:59 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionPerformance Options (right to buy) · Derivative 370 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-22-000071 · edgardoc.xml · derivative · entry 12

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,007

Underlying: Common Stock · 370 shares

Expires 2027-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
November 11, 2022 Filed Nov 14, 2022 19:59 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionPerformance Options (right to buy) · Derivative 4,630 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-22-000071 · edgardoc.xml · derivative · entry 11

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,377

Underlying: Common Stock · 4,630 shares

Expires 2027-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
November 11, 2022 Filed Nov 14, 2022 19:59 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionPerformance Options (right to buy) · Derivative 5,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-22-000071 · edgardoc.xml · derivative · entry 10

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,007

Underlying: Common Stock · 5,000 shares

Expires 2027-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
November 11, 2022 Filed Nov 14, 2022 19:59 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionPerformance Options (right to buy) · Derivative 5,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-22-000071 · edgardoc.xml · derivative · entry 9

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,007

Underlying: Common Stock · 5,000 shares

Expires 2027-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.